Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q6PJP8
UPID:
DCR1A_HUMAN
Alternative names:
Beta-lactamase DCLRE1A; SNM1 homolog A
Alternative UPACC:
Q6PJP8; D3DRC1; Q14701; Q6P5Y3; Q6PKL4
Background:
The DNA cross-link repair 1A protein, also known as Beta-lactamase DCLRE1A or SNM1 homolog A, plays a crucial role in DNA interstrand cross-link repair and cell cycle arrest in response to mitotic spindle poisons. It exhibits beta-lactamase activity, specifically hydrolyzing penicillin G and nitrocefin, while showing no activity towards other beta-lactam antibiotics like cephalosporins and carbapenems.
Therapeutic significance:
Understanding the role of DNA cross-link repair 1A protein could open doors to potential therapeutic strategies.